Form 8-K CVS HEALTH Corp For: Sep 02
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall St ends higher as stocks reclaim some shine
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Snowflake soars 20% on earnings beat and raised guidance
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
CVS Health's (CVS) Signify Health Deal to 'Bolster Health Services Business Growth' - Mizuho
September 6, 2022 12:35 PM EDTMizuho Securities analyst Ann Hynes reiterated a Buy rating and $120.00 price target on CVS Health (NYSE: CVS), saying the Signify Health deal bolsters health services business growth.
The analyst commented, "We believe this deal will accelerate CVS's value-based care initiatives through SGFY's proprietary platforms. As a reminder, at its investor day last December, CVS... More
